The first is direct induction of cancer cell apoptosis or inhibition of EpCAM cleavage into EpICD and EpEX by binding to positions Y95 and D96 of the EGF-II/TY domain (Fig. 3) on intact EpCAM. This evidence concerns the gene EPCAM and cancer.